<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - current issue</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of current issue</description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:coverDisplayDate>September 2008</prism:coverDisplayDate>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/241?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/243?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/247?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/251?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/257?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/267?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/273?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/281?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/289?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/295?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/303?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/313?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/317?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/325?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/329?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/337?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/345?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/355?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/3/363?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/241?rss=1">
<title><![CDATA[eCAM: Early Harvest]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/241?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen054</dc:identifier>
<dc:title><![CDATA[eCAM: Early Harvest]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>242</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>241</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/243?rss=1">
<title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part II]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/243?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mashelkar, R. A.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen014</dc:identifier>
<dc:title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part II]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>245</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>243</prism:startingPage>
<prism:section>Lecture Series</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/247?rss=1">
<title><![CDATA[Can Vitex Agnus Castus be Used for the Treatment of Mastalgia? What is the Current Evidence?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/247?rss=1</link>
<description><![CDATA[
<p>There have been many treatments suggested for the management of mastalgia; one of these is the fruit extract of Vitex <I>Agnus castus</I> L. commonly known as <I>Agnus castus</I>, an extract of a deciduous shrub native to Mediterranean Europe and Central Asia. It is postulated that <I>A. castus</I> suppresses the stress-induced latent hyperprolactinemia which is a release of supra-physiological levels of prolactin in some patients in response to stressful stimuli. It is postulated that <I>A. castus</I> could be effective in the treatment of cyclical mastalgia by inhibiting the release of excess prolactin by blocking Dopamine-2 receptor type on pituitary. The adverse events following <I>A. castus</I> treatment are mild and reversible. The aim of this review is assess the efficacy of <I>A. castus</I> in the treatment of mastalgia. Data from randomized and non-randomized studies regarding the efficacy and safety of <I>A. castus</I> is reviewed in a systematic fashion. It is concluded that <I>A. castus</I> can be considered as an efficient alternative phytotherapeutic agent in the treatment of mastalgia.</p>
]]></description>
<dc:creator><![CDATA[Carmichael, A.R.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem074</dc:identifier>
<dc:title><![CDATA[Can Vitex Agnus Castus be Used for the Treatment of Mastalgia? What is the Current Evidence?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>250</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>247</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/251?rss=1">
<title><![CDATA[Mechanism of Reflex Regulation of the Gastroduodenal Function by Acupuncture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/251?rss=1</link>
<description><![CDATA[
<p>Many clinical studies focus on the effects of acupuncture on digestive disorders. However, few studies describe the mechanism by which these effects are produced. We present some recent experimental work on the mechanism of acupuncture for reflex regulation of gastroduodenal function in anesthetized rats. In anesthetized rats, it has been proven that acupuncture to the abdomen excites sympathetic nerves via spinal reflexes causing inhibition of motilities while acupuncture of limbs excites vagus nerves via supraspinal reflexes causing an increase in the motilities. It has also been shown that in order to inhibit gastric motilities, acupuncture stimulation of the abdomen must be strong enough to excite group VI fibers of the afferent intercostal nerves. To increase gastric motilities, acupuncture stimulation to hind limbs must be strong enough to excite the high-threshold group III fibers of tibial nerves. It has also been shown that the neural mechanism of duodenal motility stimulation by acupuncture involves the same body regions and intensity of stimulation as that of gastric motilities. Theories regarding the underlying mechanism have proposed somato-autonomic reflexes and responses via endogenous opioids, etc., but without definitive conclusions.</p>
]]></description>
<dc:creator><![CDATA[Noguchi, E.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem077</dc:identifier>
<dc:title><![CDATA[Mechanism of Reflex Regulation of the Gastroduodenal Function by Acupuncture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>256</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>251</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/257?rss=1">
<title><![CDATA[A Possible Mechanism Underlying the Effectiveness of Acupuncture in the Treatment of Drug Addiction]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/257?rss=1</link>
<description><![CDATA[
<p>Clinical trials are currently underway to determine the effectiveness of acupuncture in the treatment of drug addiction. While there are still many unanswered questions about the basic mechanisms of acupuncture, some evidence exists to suggest that acupuncture can play an important role in reducing reinforcing effects of abused drugs. The purpose of this article is to critically review these data. The neurochemical and behavioral evidence showed that acupuncture's role in suppressing the reinforcing effects of abused drugs takes place by modulating mesolimbic dopamine neurons. Also, several brain neurotransmitter systems such as serotonin, opioid and amino acids including GABA have been implicated in the modulation of dopamine release by acupuncture. These results provided clear evidence for the biological effects of acupuncture that ultimately may help us to understand how acupuncture can be used to treat abused drugs. Additional research using animal models is of primary importance to understanding the basic mechanism underlying acupuncture's effectiveness in the treatment of drug addiction.</p>
]]></description>
<dc:creator><![CDATA[Yang, C. H., Lee, B. H., Sohn, S. H.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem081</dc:identifier>
<dc:title><![CDATA[A Possible Mechanism Underlying the Effectiveness of Acupuncture in the Treatment of Drug Addiction]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>266</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>257</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/267?rss=1">
<title><![CDATA[Comparison of Pharmacopuncture, Aquapuncture and Acepromazine for Sedation of Horses]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/267?rss=1</link>
<description><![CDATA[
<p>Pharmacopuncture, the injection of subclinical doses of drugs into acupoints reduces drug undesirable side effects, residues in animal consumption products and treatment costs in large animals. Acepromazine (Acp) produces several undesirable effects, such as hypotension. Previous studies with the injection of 1/10 of Acp dose in dog acupoints showed its advantage for sedation, minimizing undesirable effects. Eight horses were randomly submitted to four different treatment protocols according to a Latin Square double-blind design: (i) 0.1 ml kg<sup>&ndash;1</sup> of saline subcutaneously injected at the cervical region, (ii) 0.1 mg kg<sup>&ndash;1</sup> of Acp injected subcutaneously at the cervical region, (iii) 0.01 ml kg<sup>&ndash;1</sup> of saline injected into GV1 acupoint (aquapuncture) and (iv) 0.01 mg kg<sup>&ndash;1</sup> of Acp injected into GV1 acupoint (pharmacopuncture). Heart rate, respiratory rate, head height and degree of sedation were measured before and at 30, 60 and 90 min after treatments. Signs of sedation were observed in all treated groups at 30 min and only in 1/10Acp-GV1 at 60 min after the treatments. Only the group treated with 0.1 mg kg<sup>&ndash;1</sup> of Acp s.c. had significantly lower values of head height at 30 min. Respiratory rate tended to reduce in all groups but was significantly lower only in horses treated with 0.1 mg kg<sup>&ndash;1</sup> of Acp s.c. Heart rate remained unchanged in all groups. Acp-pharmacopuncture on GV1 in horses produced a mild sedation when compared with the conventional dose of Acp. More investigations are necessary to determine the optimal dosage of Acp-pharmacopuncture for sedation in horses.</p>
]]></description>
<dc:creator><![CDATA[Luna, S. P. L., Angeli, A. L., Ferreira, C. L., Lettry, V., Scognamillo-Szabo, M.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nel096</dc:identifier>
<dc:title><![CDATA[Comparison of Pharmacopuncture, Aquapuncture and Acepromazine for Sedation of Horses]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>272</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>267</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/273?rss=1">
<title><![CDATA[Entropy-Based Model for Interpreting Life Systems in Traditional Chinese Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/273?rss=1</link>
<description><![CDATA[
<p>Traditional Chinese medicine (TCM) treats <I>qi</I> as the core of the human life systems. Starting with a hypothetical correlation between TCM <I>qi</I> and the entropy theory, we address in this article a holistic model for evaluating and unveiling the rule of TCM life systems. Several new concepts such as acquired life entropy (ALE), acquired life entropy flow (ALEF) and acquired life entropy production (ALEP) are propounded to interpret TCM life systems. Using the entropy theory, mathematical models are established for ALE, ALEF and ALEP, which reflect the evolution of life systems. Some criteria are given on physiological activities and pathological changes of the body in different stages of life. Moreover, a real data-based simulation shows life entropies of the human body with different ages, Cold and Hot constitutions and in different seasons in North China are coincided with the manifestations of <I>qi</I> as well as the life evolution in TCM descriptions. Especially, based on the comparative and quantitative analysis, the entropy-based model can nicely describe the evolution of life entropies in Cold and Hot individuals thereby fitting the <I>Yin</I>&ndash;<I>Yang</I> theory in TCM. Thus, this work establishes a novel approach to interpret the fundamental principles in TCM, and provides an alternative understanding for the complex life systems.</p>
]]></description>
<dc:creator><![CDATA[Kang, G.-l., Li, S., Zhang, J.-f.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem026</dc:identifier>
<dc:title><![CDATA[Entropy-Based Model for Interpreting Life Systems in Traditional Chinese Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>279</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>273</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/281?rss=1">
<title><![CDATA[Red Cabbage (Brassica oleracea) Ameliorates Diabetic Nephropathy in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/281?rss=1</link>
<description><![CDATA[
<p>The protective action against oxidative stress of red cabbage (<I>Brassica oleracea</I>) extract was investigated. Diabetes was induced in male Wistar rats using streptozotocin (60 mg/kg body weight). Throughout the experimental period (60 days), diabetic rats exhibited many symptoms including loss of body weight, hyperglycemia, polyuria, polydipsia, renal enlargement and renal dysfunction. Significant increase in malondialdehyde, a lipid peroxidation marker, was observed in diabetic kidney. This was accompanied by a significant increase in reduced glutathione and superoxide dismutase activity and a decrease in catalase activity and in the total antioxidant capacity of the kidneys. Daily oral ingestion (1 g/kg body weight) of <I>B. oleracea</I> extract for 60 days reversed the adverse effect of diabetes in rats. <I>B. oleracea</I> extract lowered blood glucose levels and restored renal function and body weight loss. In addition, <I>B. oleracea</I> extract attenuated the adverse effect of diabetes on malondialdehyde, glutathione and superoxide dismutase activity as well as catalase activity and total antioxidant capacity of diabetic kidneys. In conclusion, the antioxidant and antihyperglycemic properties of <I>B. oleracea</I> extract may offer a potential therapeutic source for the treatment of diabetes.</p>
]]></description>
<dc:creator><![CDATA[Kataya, H. A. H., Hamza, A. A.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem029</dc:identifier>
<dc:title><![CDATA[Red Cabbage (Brassica oleracea) Ameliorates Diabetic Nephropathy in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>287</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>281</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/289?rss=1">
<title><![CDATA[Herbex-kid Inhibits Immediate Hypersensitivity Reactions in Mice and Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/289?rss=1</link>
<description><![CDATA[
<p>Herbex-kid (HK), a polyherbal formulation was evaluated in various experimental allergic models of Type I hypersensitivity reactions. Compound 48/80 (C 48/80) has been shown to induce rat mesentery mast cell degranulation and HK (1.07, 10.75 and 107.5 mg ml<sup>&ndash;1</sup>) inhibited the mast cell degranulation in a dose dependent manner. HK (1.07, 10.75 and 107.5 mg kg<sup>&ndash;1</sup>; p.o.) showed dose-dependent protection against C 48/80 induced systemic anaphylaxis in male Balb/C mice. In active anaphylaxis model, male Wistar rats orally administered with 10.75 and 107.5 mg kg<sup>&ndash;1</sup> of HK showed significant (<I>P</I> &lt; 0.01) protection against mast cell degranulation, while in passive anaphylaxis model, only at 107.5 mg kg<sup>&ndash;1</sup> showed significant (<I>P</I> &lt; 0.01) reduction in mast cell degranulation. HK at all dose levels was able to significantly decrease the time spent in nasal rubbing in Wistar rats sensitized to ovalbumin, while only at 107.5 mg kg<sup>&ndash;1</sup> it showed significant (<I>P</I> &lt; 0.01) reduction in number of sneezes. In C 48/80-induced skin itch model, all dose levels of HK significantly (<I>P</I> &lt; 0.001) decreased the time spent in itching and the number of itches. HK did not produce any significant inhibition in histamine induced contraction in guinea pig ileum. From the above findings we conclude that the HK possesses antiallergic activity mediated by reducing of the release mediators from mast cells and also by 5-HT antagonism without the involvement of histamine (H1) receptors.</p>
]]></description>
<dc:creator><![CDATA[Kumar, A., Prasad, R., Jogge, N. M., Bhojraj, S., Emerson, S. F., Prabakar, S.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem034</dc:identifier>
<dc:title><![CDATA[Herbex-kid Inhibits Immediate Hypersensitivity Reactions in Mice and Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>294</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>289</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/295?rss=1">
<title><![CDATA[Estrogenic Activities of Fatty Acids and a Sterol Isolated from Royal Jelly]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/295?rss=1</link>
<description><![CDATA[
<p>We have previously reported that royal jelly (RJ) from honeybees (<I>Apis mellifera</I>) has weak estrogenic activity mediated by interaction with estrogen receptors that leads to changes in gene expression and cell proliferation. In this study, we isolated four compounds from RJ that exhibit estrogenic activity as evaluated by a ligand-binding assay for the estrogen receptor (ER) &beta;. These compounds were identified as 10-hydroxy-<I>trans</I>-2-decenoic acid, 10-hydroxydecanoic acid, <I>trans</I>-2-decenoic acid and 24-methylenecholesterol. All these compounds inhibited binding of 17&beta;-estradiol to ER&beta;, although more weakly than diethylstilbestrol or phytoestrogens. However, these compounds had little or no effect on the binding of 17&beta;-estradiol to ER. Expression assays suggested that these compounds activated ER, as evidenced by enhanced transcription of a reporter gene containing an estrogen-responsive element. Treatment of MCF-7 cells with these compounds enhanced their proliferation, but concomitant treatment with tamoxifen blocked this effect. Exposure of immature rats to these compounds by subcutaneous injection induced mild hypertrophy of the luminal epithelium of the uterus, but was not associated with an increase in uterine weight. These findings provide evidence that these compounds contribute to the estrogenic effect of RJ.</p>
]]></description>
<dc:creator><![CDATA[Suzuki, K.-M., Isohama, Y., Maruyama, H., Yamada, Y., Narita, Y., Ohta, S., Araki, Y., Miyata, T., Mishima, S.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem036</dc:identifier>
<dc:title><![CDATA[Estrogenic Activities of Fatty Acids and a Sterol Isolated from Royal Jelly]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>302</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>295</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/303?rss=1">
<title><![CDATA[Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/303?rss=1</link>
<description><![CDATA[
<p>Several transcription factors (TFs) play crucial roles in governing the expression of different genes involved in the immune response, embryo or cell lineage development, cell apoptosis, cell cycle progression, oncogenesis, repair and fibrosis processes and inflammation. As far as inflammation, TFs playing pivotal roles are nuclear factor kappa B (NF-kB), activator protein (AP-1), signal transducer and activator of transcription (STATs), cAMP response element binding protein (CREB) and GATA-1 factors. All these TFs regulate the expression of pro-inflammatory cytokines and are involved in the pathogenesis of a number of human disorders, particularly those with an inflammatory component. Since several medicinal plants can be employed to produce extracts exhibiting biological effects and because alteration of gene transcription represents a very interesting approach to control the expression of selected genes, this study sought to verify the ability of several extracts derived from Bangladeshi medicinal plants in interfering with molecular interactions between different TFs and specific DNA sequences. We first analyzed the antiproliferative activity of 19 medicinal plants on different human cell lines, including erythroleukemia K562, B lymphoid Raji and T lymphoid Jurkat cell lines. Secondly, we employed the electrophoretic mobility shift assay as a suitable technique for a fast screening of plant extracts altering the binding between NF-kB, AP-1, GATA-1, STAT-3, CREB and the relative target DNA elements.</p>
]]></description>
<dc:creator><![CDATA[Lampronti, I., Khan, M. T.H., Borgatti, M., Bianchi, N., Gambari, R.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem042</dc:identifier>
<dc:title><![CDATA[Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>312</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>303</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/313?rss=1">
<title><![CDATA[Chemical Composition and Botanical Origin of Red Propolis, a New Type of Brazilian Propolis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/313?rss=1</link>
<description><![CDATA[
<p>Red propolis is a new type of Brazilian propolis. This material, as well as the secretions of 20 plant species that are often mentioned as its probable botanical source, have been investigated by RP-HPTLC. Phytochemical evidence based on UV-VIS spectra, RP-HPLC and GC-MS, showed <I>Dalbergia ecastophyllum</I> (L.) Taub. to be the main source of red propolis in Alagoas state. The propolis and plant resin showed high relative percentages of the isoflavonoids 3-Hydroxy-8,9-dimethoxypterocarpan and medicarpin. To our knowledge this is the first report of the secretion of a leguminous species being the source of propolis.</p>
]]></description>
<dc:creator><![CDATA[Silva, B. B., Rosalen, P. L., Cury, J. A., Ikegaki, M., Souza, V. C., Esteves, A., Alencar, S. M.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem059</dc:identifier>
<dc:title><![CDATA[Chemical Composition and Botanical Origin of Red Propolis, a New Type of Brazilian Propolis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>316</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>313</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/317?rss=1">
<title><![CDATA[Brazilian Propolis: Correlation Between Chemical Composition and Antimicrobial Activity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/317?rss=1</link>
<description><![CDATA[
<p>The chemical composition of ethanol extracts from samples of Brazilian propolis (EEPs) determined by HPLC and their activity against <I>Trypanosoma cruzi</I>, <I>Staphylococcus aureus</I>, <I>Streptococcus pneumoniae</I>, <I>Klebisiella pneumoniae</I>, <I>Candida albicans</I>, <I>Sporothrix schenckii</I> and <I>Paracoccidioides brasiliensis</I> were determined. Based on the predominant botanical origin in the region of samples' collection, the 10 extracts were separated into three groups: A (<I>B. dracunculifolia</I> + <I>Auraucaria</I> spp), B (<I>B. dracunculifolia</I>) and C (<I>Araucaria</I> spp). Analysis by the multiple regression of all the extracts together showed a positive correlation, higher concentrations leading to higher biological effect, of <I>S. aureus</I> with <I>p</I>-coumaric acid (PCUM) and 3-(4-hydroxy-3-(oxo-butenyl)-phenylacrylic acid (DHCA1) and of trypomastigotes of <I>T. cruzi</I> with 3,5-diprenyl-4-hydroxycinnamic acid derivative 4 (DHCA4) and 2,2-dimethyl-6-carboxyethenyl-2H-1-benzopyran (DCBEN). When the same approach was employed for each group, due to the small number of observations, the statistical test gave unreliable results. However, an overall analysis revealed for group A an association of <I>S. aureus</I> with caffeic acid (CAF) and dicaffeoylquinic acid 3 (CAFQ3), of <I>S. pneumoniae</I> with CAFQ3 and monocaffeoylquinic acid 2 (CAFQ2) and of <I>T. cruzi</I> also with CAFQ3. For group B, a higher activity against <I>S. pneumoniae</I> was associated DCBEN and for <I>T. cruzi</I> with CAF. For group C no association was observed between the anitmicrobial effect and any component of the extracts. The present study reinforces the relevance of PCUM and derivatives, especially prenylated ones and also of caffeolyquinic acids, on the biological activity of Brazilian propolis.</p>
]]></description>
<dc:creator><![CDATA[Salomao, K., Pereira, P. R. S., Campos, L. C., Borba, C. M., Cabello, P. H., Marcucci, M. C., de Castro, S. L.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem058</dc:identifier>
<dc:title><![CDATA[Brazilian Propolis: Correlation Between Chemical Composition and Antimicrobial Activity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>324</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>317</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/325?rss=1">
<title><![CDATA[Aromatherapy Massage Affects Menopausal Symptoms in Korean Climacteric Women: A Pilot-Controlled Clinical Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/325?rss=1</link>
<description><![CDATA[
<p>This study investigated the effects of aromatherapy massage on menopausal symptoms in Korean climacteric women. Kupperman's menopausal index was used to compare an experimental group of 25 climacteric women with a wait-listed control group of 27 climacteric women. Aromatherapy was applied topically to subjects in the experimental group in the form of massage on the abdomen, back and arms using lavender, rose geranium, rose and jasmine in almond and primrose oils once a week for 8 weeks (eight times in total). The experimental group reported a significantly lower total menopausal index than wait-listed controls (<I>P</I> &lt; 0.05). There were also significant intergroup differences in subcategories such as vasomotor, melancholia, arthralgia and myalgia (all <I>P</I> &lt; 0.05). These findings suggest that aromatherapy massage may be an effective treatment of menopausal symptoms such as hot flushes, depression and pain in climacteric women. However, it could not be verified whether the positive effects were from the aromatherapy, the massage or both. Further rigorous studies should be done with more objective measures.</p>
]]></description>
<dc:creator><![CDATA[Hur, M.-H., Yang, Y. S., Lee, M. S.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem027</dc:identifier>
<dc:title><![CDATA[Aromatherapy Massage Affects Menopausal Symptoms in Korean Climacteric Women: A Pilot-Controlled Clinical Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>328</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>325</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/329?rss=1">
<title><![CDATA[Chondroprotective Potential of Fruit Extracts of Phyllanthus emblica in Osteoarthritis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/329?rss=1</link>
<description><![CDATA[
<p>There is a need for effective nutraceuticals for osteoarthritis care. The fruit of <I>Phyllanthus emblica</I> is used as a powerful rejuvenator in Ayurvedic medicine. This study measured the chondroprotective potential of <I>P. emblica</I> (&lsquo;Amalaki&rsquo;) fruits <I>in vitro</I>. We used aqueous extracts of unprocessed <I>P. emblica</I> fruit powder (powder A), and the powder obtained after hot water extraction and drying of powder A (powder B). Chondroprotection was measured in three different assay systems. First, we tested the effects of both fruit powders on the activities of the enzymes hyaluronidase and collagenase type 2. Second, an <I>in vitro</I> model of cartilage degradation was set-up with explant cultures of articular knee cartilage from osteoarthritis patients. Cartilage damage was assayed by measuring glycosaminoglycan release from explants treated with/without <I>P. emblica</I> fruit powders. Aqueous extracts of both fruit powders significantly inhibited the activities of hyaluronidase and collagenase type 2 <I>in vitro</I>. Third, in the explant model of cartilage matrix damage, extracts of glucosamine sulphate and powder B (0.05 mg/ml) exhibited statistically significant, long-term chondroprotective activity in cartilage explants from 50% of the patients tested. This result is important since glucosamine sulphate is the leading nutraceutical for osteoarthritis. Powder A induced a statistically significant, short-term chondroprotective activity in cartilage explants from all of the patients tested. This is the first study to identify and quantitate new chondroprotective activities of <I>P. emblica</I> fruits. These data provide pilot pre-clinical evidence for the use of <I>P. emblica</I> fruits as a chondroprotective agent in osteoarthritis therapy.</p>
]]></description>
<dc:creator><![CDATA[Sumantran, V. N., Kulkarni, A., Chandwaskar, R., Harsulkar, A., Patwardhan, B., Chopra, A., Wagh, U. V.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem030</dc:identifier>
<dc:title><![CDATA[Chondroprotective Potential of Fruit Extracts of Phyllanthus emblica in Osteoarthritis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>335</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>329</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/337?rss=1">
<title><![CDATA[A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/337?rss=1</link>
<description><![CDATA[
<p>We determined the therapeutic efficacy of atractylenolide I (ATR), extracted from largehead atractylodes rhizome, in managing gastric cancer cachexia (GCC), and interpreted its probable pharmacological mechanism via investigating tumor necrosis factor alpha (TNF-), interleukin-1 (IL-1), interleukin-6 (IL-6) and proteolysis-inducing factor (PIF). This was a randomized but not-blinded pilot. The study group (<I>n</I> = 11) received 1.32 g per day of atractylenolide I (ATR) and the control group (<I>n</I> = 11) received 3.6 g per day of fish-oil-enriched nutritional supplementation (FOE) for 7 weeks. Conservative therapy was similar in both groups. Clinical [appetite, body weight, mid-arm muscle circumference (MAMC), Karnofsky performance status (KPS) status], biomarker (TNF-, IL-1, IL-6 and PIF) were evaluated in the basal state, at the third and seventh weeks. To analyze changes of cytokines, an immumohistochemistry technique was adopted. Base line characteristics were similar in both groups. Effects on MAMC and body weight increase, TNF- increase and IL-1 decreases of serum level were significant in both groups (<I>P</I> &lt; 0.05). ATR was significantly more effective than FOE in improving appetite and KPS status, and decreasing PIF positive rate (<I>P</I> &lt; 0.05). Slight nausea (3/11) and dry mouth (1/11) were shown in intervention groups but did not interrupt treatment. These preliminary findings suggest that ATR might be beneficial in alleviating symptoms, in modulating cytokine and in inhibiting PIF proteolysis of gastric cancer cachexia. Further research using a randomized controlled design is necessary to confirm these pilot study findings.</p>
]]></description>
<dc:creator><![CDATA[Liu, Y., Jia, Z., Dong, L., Wang, R., Qiu, G.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem031</dc:identifier>
<dc:title><![CDATA[A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>344</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>337</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/345?rss=1">
<title><![CDATA[Dominican Children with HIV not Receiving Antiretrovirals: Massage Therapy Influences their Behavior and Development]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/345?rss=1</link>
<description><![CDATA[
<p>Forty-eight children (<I>M</I> age = 4.8 years) infected with HIV/AIDS and living in the Dominican Republic were randomly assigned to a massage therapy or a play session control group. The children in the massage therapy group received two weekly 20-min massages for 12 weeks; the children in the control group participated in a play session (coloring, playing with blocks) for the same duration and length as the massage therapy group. Overall, the children in the massage therapy group improved in self-help abilities and communication, suggesting that massage therapy may enhance daily functioning for children with HIV/AIDS. Moreover, the HIV infected children who were six or older also showed a decrease in internalizing behaviors; specifically depressive/anxious behaviors and negative thoughts were reduced. Additionally, baseline assessments revealed IQ equivalence below normal functioning for 70% of the HIV infected children and very high incidences of mood problems (depression, withdrawn) for 40% of the children and anxiety problems for 20% of the children, suggesting the need for better monitoring and alternative interventions in countries with limited resources to improve cognition and the mental health status of children infected with HIV/AIDS.</p>
]]></description>
<dc:creator><![CDATA[Hernandez-Reif, M., Shor-Posner, G., Baez, J., Soto, S., Mendoza, R., Castillo, R., Quintero, N., Perez, E., Zhang, G.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem032</dc:identifier>
<dc:title><![CDATA[Dominican Children with HIV not Receiving Antiretrovirals: Massage Therapy Influences their Behavior and Development]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>354</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>345</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/355?rss=1">
<title><![CDATA[An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/355?rss=1</link>
<description><![CDATA[
<p>Natural herbal medicine (NHM) has been used to control infectious diseases for thousands of years. In view of the possible beneficial effect of NHM on SARS, we conducted this study to examine whether NHM is of any benefit as a supplementary treatment of SARS or SARS-like infectious disease. This was a randomized, double-blind, placebo-controlled trial. Twenty-eight patients fulfilled the WHO inclusion criteria and our exclusion criteria. All enrolled patients received routine western-medicine treatment. Patients were randomly allocated to one of the three supplementary treatment groups: NHM A (Group A, <I>n</I> = 9) NHM B (Group B, <I>n</I> = 9) or placebo (Group C, <I>n</I> = 10). Chest X-ray was done every 1 or 2 days for every patient. Reading radiologists use a standard 0&ndash;3 scoring system (0: no infiltration; 1: focal haziness or even small patchy lesion; 2: ground glass picture; 3: lobar consolidation) according to the severity of infiltration in each lung field (three lung fields in both right and left lungs). The main outcome measurements were the improving chest radiographic scores (IRS) and the duration (days) till improvement (DI). One patient from the placebo group passed away. Patients from NHM A took less days before showing improvement (6.7 &plusmn; 1.8) compared with placebo group (11.2 &plusmn; 4.9), which showed statistical significance (<I>P</I> = 0.04). The cases were too few to be conclusive, the initial observations seem to indicate NHM appears to be safe in non-criticallly ill patients and clinical trials are feasible in the setting of pandemic outbreaks.</p>
]]></description>
<dc:creator><![CDATA[Hsu, C.-H., Hwang, K.-C., Chao, C.-L., Chang, S. G. N., Ho, M.-S., Lin, J.-G., Chang, H.-H., Kao, S.-T., Chen, Y.-M., Chou, P.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem035</dc:identifier>
<dc:title><![CDATA[An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>362</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>355</prism:startingPage>
<prism:section>Original Article - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/3/363?rss=1">
<title><![CDATA[Traditional Arabic and Islamic Medicine (TAIM) now joins TCM CAM, Kampo and Ayurveda]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/3/363?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Azaizeh, H., Saad, B., Cooper, E., Said, O.]]></dc:creator>
<dc:date>2008-09-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem157</dc:identifier>
<dc:title><![CDATA[Traditional Arabic and Islamic Medicine (TAIM) now joins TCM CAM, Kampo and Ayurveda]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>364</prism:endingPage>
<prism:publicationDate>2008-09-01</prism:publicationDate>
<prism:startingPage>363</prism:startingPage>
<prism:section>Meeting Report</prism:section>
</item>

</rdf:RDF>